Atlas Trials

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer

Clinical trial NCT06059014 · COMPLETED

Trial details

NCT number
NCT06059014
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Clear Cell Renal Cell Carcinoma
Start date
2023-11-09
Primary completion
2025-07-16
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.